-
Adding Maraviroc to Suppressive ART Will Not Boost CD4-Cell Counts
Adding maraviroc to ART is not a useful strategy for boosting CD4-cell counts in immunologic nonresponders.
October 04, 2012
-
Low-Level Viremia in HIV-Infected Patients
Is low-level viremia associated with a higher rate of viral rebound?
September 20, 2012
-
HIV-1 and HIV-2: A Tale of Two Viruses
Does dual infection with HIV1 and HIV2 slow the progression to AIDS?
September 06, 2012
-
PrEP in Heterosexual Adults
How effective is HIV pre-exposure prophylaxis in heterosexual adults?
August 23, 2012
-
The 'When to Start ART' Debate
Higher CD4-cell counts during ART treatment are associated with lower mortality rates.
August 09, 2012
-
PEPFAR Funding Leads to Significant Reductions in Adult Mortality
The PEPFAR program in Africa is associated with significant reductions in all-cause mortality.
July 26, 2012
-
HBV Reactivation in an HIV-Infected Patient
Can HBV infection reactivate in HIV patients who are receiving corticosteroids?
July 05, 2012
-
Efavirenz Better Than Nevirapine for Most Patients
For most patients, efavirenz is preferred over nevirapine, but why?
June 21, 2012
-
The Clinical Consequences of Transmitted HIV-drug Resistance
Treatment failure may still occur even when the regimen appears to be fully active based on resistance testing. What is going wrong?
June 04, 2012
-
Undetectable Viral Load - Not a Guarantee Against Transmitting HIV
The risk for HIV transmission is not eliminated by suppressive ART.
May 21, 2012
-
Time to Change the PEP Guidelines?
Should raltegravir-based regimens be used as a first-line option for postexposure prophylaxis?
May 07, 2012
-
Tenofovir + 3TC + Nevirapine Not Equal to Other WHO-recommended Regimens
Is Tenofovir + 3TC + Nevirapine equal to other recommended regimens?
April 23, 2012
-
Nevirapine or Efavirenz: Which Is Best for Women of Childbearing Age?
Which ART regimen is best for women of childbearing age?
April 09, 2012
-
What Is IRIS Like in the U.S.?
How is IRIS different in the U.S. than in other countries?
March 26, 2012
-
Virologic Failure on Rilpivirine May Lead to Broad NNRTI Resistance
Rilpivirine-based ART is well tolerated, but may cause NNRTI resistance.
February 28, 2012
-
HIV Viral Loads - the Lower, the Better?
Do very low levels of HIV virus effect the development of virologic failure?
February 16, 2012
-
The Latest "Vital Signs" for the U.S. HIV Epidemic Suggest an Emergency
The latest nationwide data illustrate the need for much greater effort across the spectrum of care for HIV/AIDS.
February 01, 2012
-
What Are the Implications of Poor Immunologic Response to ART?
Some HIV-infected patients do not experience adequate CD4-cell recovery after ART. What are the implications for these patients?
January 19, 2012
-
HIV and Clinical Manifestations of Accelerated Aging
HIV infected individuals experience chronic conditions at a younger age and greater frequency than the general population.
January 03, 2012
-
Lower Rates of Resistance With Newer ART Regimens
Which newer ART regimens are associated with a lower frequency of resistance?
December 21, 2011
